Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells

Bioscience Reports

Volumn 34, Issue 4, 2014, Pages 415-427

  Dowling, Catríona M ^a   Herranz Ors, Carmen ^a   Kiely, Patrick A ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Cancer progression; Colon cancer; Real time cell analysis; Stromal environment; xCELLigence

Indexed keywords

CULTURE MEDIUM;

CELL ADHESION; CELL MOTION; CELL PROLIFERATION; COLON TUMOR; CULTURE MEDIUM; EXTRACELLULAR MATRIX; FIBROBLAST; HCT116 CELL LINE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION; TUMOR MICROENVIRONMENT;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; CULTURE MEDIA; EXTRACELLULAR MATRIX; FIBROBLASTS; HCT116 CELLS; HUMANS; NEOPLASM INVASIVENESS; TUMOR MICROENVIRONMENT;

EID: 84906859031     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20140031     Document Type: Article

References (51)

1. Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674 CrossRef PubMed
2. Liotta, L. A. and Kohn, E. C. (2001) The microenvironment of the tumour-host interface. Nature 411, 375-379 CrossRef PubMed
3. Mueller, M. M. and Fusenig, N. E. (2004) Friends or foes-bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4, 839-849 CrossRef PubMed (Pubitemid 39472951)
4. De Wever, O. and Mareel, M. (2003) Role of tissue stroma in cancer cell invasion. J. Pathol. 200, 429-447 CrossRef PubMed (Pubitemid 36818244)
5. Feng, S., Dakhova, O., Creighton, C. J. and Ittmann, M. (2013) Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression. Cancer Res. 73, 2551-2562 CrossRef PubMed
6. Ferrara, N. (2010) Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis. Curr. Opin. Hematol. 17, 219-224 PubMed
7. Falcon, B. L., Pietras, K., Chou, J., Chen, D., Sennino, B., Hanahan, D. and McDonald, D. M. (2011) Increased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor-B. Am. J. Pathol. 178, 2920-2930 CrossRef PubMed
8. Mazzoleni, S., Politi, L. S., Pala, M., Cominelli, M., Franzin, A., Sergi Sergi, L., Falini, A., De Palma, M., Bulfone, A., Poliani, P. L. and Galli, R. (2010) Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res. 70, 7500-7513 CrossRef PubMed
9. Calon, A., Espinet, E., Palomo-Ponce, S., Tauriello, D. V., Iglesias, M., Céspedes, M. V., Sevillano, M., Nadal, C., Jung, P., Zhang, X. H. et al. (2012) Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell 22, 571-584 CrossRef PubMed
10. Pickup, M., Novitskiy, S. and Moses, H. L. (2013) The roles of TGF [beta] in the tumour microenvironment. Nat. Rev. Cancer 13, 788-799 CrossRef PubMed
11. Quail, D. F. and Joyce, J. A. (2013) Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423-1437 CrossRef PubMed
12. Christiansen, V. J., Jackson, K. W., Lee, K. N., Downs, T. D. and McKee, P. A. (2013) Targeting inhibition of fibroblast activation protein-á and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments. Neoplasia (NY) 15, 348
13. Paraiso, K. H. and Smalley, K. S. (2013) Fibroblast-mediated drug resistance in cancer. Biochem. Pharmacol. 85, 1033-1041 CrossRef PubMed
14. Junttila, M. R. and de Sauvage, F. J. (2013) Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346-354 CrossRef PubMed
15. Taddei, M. L., Giannoni, E., Comito, G. and Chiarugi, P. (2013) Microenvironment and tumor cell plasticity: an easy way out. Cancer Lett. 341, 80-96 CrossRef PubMed
16. Li, H., Fan, X. and Houghton, J. (2007) Tumor microenvironment: the role of the tumor stroma in cancer. J. Cel. Biochem. 101, 805-815 CrossRef (Pubitemid 47040863)
17. Xing, F., Saidou, J. and Watabe, K. (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front. Biosci. 15, 166 CrossRef
18. McAnulty, R. J. (2007) Fibroblasts and myofibroblasts: their source, function and role in disease. Int. J. Biochem. Cell Biol. 39, 666-671 CrossRef PubMed
19. Cirri, P. and Chiarugi, P. (2011) Cancer associated fibroblasts: the dark side of the coin. Am. J. Cancer Res. 1, 482 PubMed
20. Kurose, K., Gilley, K., Matsumoto, S., Watson, P. H., Zhou, X. P. and Eng, C. (2002) Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat. Gen. 32, 355-357 CrossRef (Pubitemid 35266108)
21. Krtolica, A. (2014) Role of microenvironment in regulating stem cell and tumor initiating cancer cell behavior and its potential therapeutic implications. In Tumor Dormancy, Quiescence, and Senescence, Volume 2, pp. 301-312 Springer CrossRef
22. Kalluri, R. and Zeisberg, M. (2006) Fibroblasts in cancer. Nat. Rev. Cancer 6, 392-401 CrossRef PubMed
23. Pepper, M. S. (2001) Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21, 1104-1117 CrossRef PubMed
24. Sato, T., Sakai, T., Noguchi, Y., Takita, M., Hirakawa, S. and Ito, A. (2004) Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol. Oncol. 92, 47-56 CrossRef PubMed (Pubitemid 38147370)
25. Stetler-Stevenson, W. G. and Yu, A. E. (2001) Proteases in invasion: matrix metalloproteinases. In Seminars in Cancer Biology, Elsevier
26. Ke, N., Wang, X., Xu, X. and Abassi, Y. A. (2011) The xCELLigence system for real-time and label-free monitoring of cell viability. In Mammalian Cell Viability (M. J., Stoddart, ed.), pp. 33-43, Springer CrossRef
27. Ke, N., Wang, X., Xu, X. and Abassi, Y. A. (2010) The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol. Biol. 740, 33-43 CrossRef
28. Moniri, M. R., Young, A., Reinheimer, K., Rayat, J., Dai, L. J. and Warnock, G. L. (2014) Dynamic assessment of cell viability, proliferation and migration using real time cell analyzer system (RTCA). Cytotechnology, in the press
29. Prasadam, I., Zhou, Y., Du, Z., Chen, J., Crawford, R. and Xiao, Y. (2014) Osteocyte-induced angiogenesis via VEGF-MAPK-dependent pathways in endothelial cells. Mol. Cell. Biochem. 386, 15-25 CrossRef PubMed
30. Meindl, C., Absenger, M., Roblegg, E. and Fröhlich, E. (2013) Suitability of cell-based label-free detection for cytotoxicity screening of carbon nanotubes. BioMed. Res. Int. 2013, 564804 CrossRef PubMed
31. van Oosterwijk, J., van Ruler, M. A., Briaire-de Bruijn, I. H., Herpers, B., Gelderblom, H., van de Water, B. and Bovée, J. V. (2013) Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells. Br. J. Cancer 109, 1214-1222 CrossRef PubMed
32. Kramer, A. H., Joos-Vandewalle, J., Edkins, A. L., Frost, C. L. and Prinsloo, E. (2014) Real-time monitoring of 3T3-L1 preadipocyte differentiation using a commercially available electric cell-substrate impedance sensor system. Biochem. Biophys. Res. Commun. 443, 1245-1250 CrossRef PubMed
33. Dwane, S., Durack, E. and Kiely, P. (2013) Optimising parameters for the differentiation of SH-SY5Y cells to study cell adhesion and cell migration. BMC Res. Notes 6, 366 CrossRef PubMed
34. Barcellos-Hoff, M. H., Lyden, D. and Wang, T. C. (2013) The evolution of the cancer niche during multistage carcinogenesis. Nat. Rev. Cancer 13, 511-518 CrossRef PubMed
35. Werfel, J., Krause, S., Bischof, A. G., Mannix, R. J., Tobin, H., Bar-Yam, Y., Bellin, R. M. and Ingber, D. E. (2013) How changes in extracellular matrix mechanics and gene expression variability might combine to drive cancer progression. PLoS ONE 8, e76122 CrossRef PubMed
36. Hou, X. Q., Yan, R., Yang, C., Zhang, L., Su, R. Y., Liu, S. J., Zhang, S. J., He, W. Q., Fang, S. H., Cheng, S. Y. et al. (2014) A novel assay for high-throughput screening of anti-Alzheimer's disease drugs to determine their efficacy by real-time monitoring of changes in PC12 cell proliferation. Int. J. Mol. Med. 33, 543-549 PubMed
37. Lohberger, B., Stuendl, N., Wolf, E., Liegl-Atzwanger, B., Leithner, A. and Rinner, B. (2013) The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity. BMC Cancer 13, 563 CrossRef PubMed
38. Ebersohn, K., Coetzee, P. and Venter, E. H. (2014) An improved method for determining virucidal efficacy of a chemical disinfectant using an electrical impedance assay. J. Virol. Methods 199, 25-28 CrossRef PubMed
39. Limame, R., Wouters, A., Pauwels, B., Fransen, E., Peeters, M., Lardon, F., De Wever, O. and Pauwels, P. (2012) Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS ONE 7, e46536 CrossRef PubMed
40. Darbre, P. D., Bakir, A. and Iskakova, E. (2013) Effect of aluminium on migratory and invasive properties of MCF-7 human breast cancer cells in culture. J. Inorg. Biochem. 128, 245-249 CrossRef PubMed
41. Ramis, G., Martínez-Alarcón, L., Quereda, J. J., Mendonça, L., Majado, M. J., Gomez-Coelho, K., Mrowiec, A., Herrero-Medrano, J. M., Abellaneda, J. M., Pallares, F. J. et al. (2013) Optimization of cytotoxicity assay by real-time, impedance-based cell analysis. Biomed. Microdevices 15, 985-995 CrossRef PubMed
42. Tan, Y. F., Mundargi, R. C., Chen, M. H., Lessig, J., Neu, B., Venkatraman, S. S. and Wong, T. T. (2014) Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing. Small 8, 201303201
43. Kiely, P. A., Leahy, M., O'Gorman, D. and O'Connor, R. (2005) RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251. J. Biol. Chem. 280, 7624-7633 CrossRef PubMed (Pubitemid 40349655)
44. Kiely, P. A., Baillie, G. S., Lynch, M. J., Houslay, M. D. and O'Connor, R. (2008) Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta1 integrin and for tumor cell proliferation and migration. J. Biol. Chem. 283, 22952-22961 CrossRef PubMed
45. Mertens, J. C., Fingas, C. D., Christensen, J. D., Smoot, R. L., Bronk, S. F., Werneburg, N. W., Gustafson, M. P., Dietz, A. B., Roberts, L. R., Sirica, A. E. and Gores, G. J. (2013) Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. Cancer Res. 73, 897-907 CrossRef PubMed
46. Cirri, P. and Chiarugi, P. (2012) Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev. 31, 195-208 CrossRef PubMed
47. Eleniste, P. P. and Bruzzaniti, A. (2012) Focal adhesion kinases in adhesion structures and disease. J. Signal Transduct. 2012: 296450 CrossRef PubMed
48. Guan, J. L. (2010) Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life 62, 268-276 CrossRef PubMed
49. Schlaepfer, D. D. and Mitra, S. K. (2004) Multiple connections link FAK to cell motility and invasion. Curr. Opin. Genet. Dev. 14, 92-101 CrossRef PubMed (Pubitemid 38167483)
50. Dwane, S., Durack, E., O'Connor, R. and Kiely, P. A. (2014) RACK1 promotes neurite outgrowth by scaffolding AGAP2 to FAK. Cell. Signal. 26, 9-18 CrossRef PubMed
51. Lawson, C. and Schlaepfer, D. D. (2012) Integrin adhesions: Who's on first? What's on second? Cell Adhes. Migration 6, 302-306